Does CARFILZOMIB Cause Intentional product use issue? 168 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 168 reports of Intentional product use issue have been filed in association with CARFILZOMIB (KYPROLIS). This represents 0.8% of all adverse event reports for CARFILZOMIB.
168
Reports of Intentional product use issue with CARFILZOMIB
0.8%
of all CARFILZOMIB reports
10
Deaths
28
Hospitalizations
How Dangerous Is Intentional product use issue From CARFILZOMIB?
Of the 168 reports, 10 (6.0%) resulted in death, 28 (16.7%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Intentional product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARFILZOMIB. However, 168 reports have been filed with the FAERS database.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Intentional product use issue?
INFLIXIMAB (11,028)
RITUXIMAB (9,602)
INFLIXIMAB-DYYB (7,549)
TOCILIZUMAB (5,078)
METHOTREXATE (4,087)
PREDNISONE (3,961)
ABATACEPT (3,693)
ADALIMUMAB (3,557)
NIVOLUMAB (3,297)
LEFLUNOMIDE (3,280)
Which CARFILZOMIB Alternatives Have Lower Intentional product use issue Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL